Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02891681 · ClinicalTrials.gov registry record · NA
Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment
A NA study of Breast Cancer and Cancer of the Breast, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT02891681 is a NA study of Breast Cancer and Cancer of the Breast that has completed, run by Washington University School of Medicine. The registered enrollment target is 41 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02891681, a NA study of Breast Cancer and Cancer of the Breast, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the accuracy of NIR/US assessment of tumor vasculature and oxygen changes in predicting and monitoring early neoadjuvant treatment response compared to pathological response.
Conditions Studied
Interventions
- DEVICE Optical Tomography Using Near Infrared Diffused Light Assisted with Ultrasound
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2016-11-29 |
| Est. Completion | 2020-01-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02891681
The ClinicalTrials.gov registry entry for NCT02891681 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Optical Tomography Using Near Infrared Diffused Light Assisted with Ultrasound is the first listed.
NCT02891681 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT02891681 about?
NCT02891681 is a clinical study titled "Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment". To determine the accuracy of NIR/US assessment of tumor vasculature and oxygen changes in predicting and monitoring early neoadjuvant treatment response compared to pathological response.
What is the current status of trial NCT02891681?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2016-11-29. Estimated completion is 2020-01-23.
What conditions does trial NCT02891681 study?
This clinical trial studies the following conditions: Breast Cancer, Cancer of the Breast, Malignant Neoplasm of Breast, Cancer of Breast, Breast Tumors.
What interventions are being tested in trial NCT02891681?
The interventions under investigation include: Optical Tomography Using Near Infrared Diffused Light Assisted with Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT02891681?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02891681 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.